Exosomes & PDRN: What's Proven vs What's Still Being Tested

Regenerative skincare is the current frontier, and exosomes and PDRN are its two poster ingredients. Both come from real biology. Both are sold well ahead of the evidence. Separating the two matters, because they are not at the same stage.

PDRN, briefly

PDRN is a mixture of DNA fragments, most commonly salmon-derived, used in clinics for years and now common in Korean topical formulas. The proposed mechanism is adenosine-receptor signalling that supports repair and reduces inflammation.

The clinical work sits mostly with injected use, in wound healing and post-procedure recovery. Topical work is newer and smaller, but the direction is consistent: calmer, better-hydrated, less reactive skin. Our PDRN ingredient page tracks the specifics.

Exosomes, less briefly

Exosomes are tiny vesicles cells use to carry signalling molecules. In a laboratory they demonstrably change how neighbouring cells behave, which is why the interest is genuine.

The problems are practical:

• Source and standardisation vary enormously between products, and rarely appear on a label.
• They are fragile. Whether an intact vesicle survives a jar, a shelf and an intact skin barrier is an open question.
• Most published human data involves in-clinic delivery after microneedling or laser, not a cream applied at home.
• Regulatory positions differ by country, and some markets restrict them entirely.

How to think about your money

If you want firmness and texture change with the strongest evidence base, that is still a retinoid plus daily SPF — start with retinal vs retinol. PDRN is a reasonable addition for comfort and recovery. Exosome creams are early-stage: interesting, not foundational.

Cosmetic information only. In-clinic regenerative treatments are medical procedures and belong in a conversation with a qualified practitioner.